Verifying…
Home / Drug A–Z / Zilatec 150 Tablets

Zilatec 150 Tablets

NAFDAC Reg. No. A4-1681 · Drug

Registered with NAFDAC. Registration activeAs of 28 October 2026 · synced automatically from official sources.
Product
Zilatec 150 Tablets
NAFDAC number
A4-1681
Active ingredient
Ranitidine (Ranitidine Hydrochloride)
Strength
150 mg
Form
Tablet
Pack size
2 x 10's, 20 x 10's, 10 x 10's (in Alu-Alu strips)
Manufacturer
Not listed
Applicant (holder)
Nisenton Pharmaceuticals Limited
Approved
24 Jun 2021
Status
Inactive View on NAFDAC ↗
Registration valid to
23 Jun 2026
WHO alerts
None found
Community reports
None
Times checked
0

What we found

  • Zilatec 150 Tablets is on the NAFDAC register with an active registration (A4-1681). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

What Zilatec 150 Tablets is used for

From the official U.S. FDA label for ranitidine (ranitidine hydrochloride), the active ingredient registered with NAFDAC.

What it is used for

(s) relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages

Purpose

Acid reducer

Possible side effects

Stop use and ask doctor if your heartburn continues or worsens you need to take this product for more than 14 days

Do not use if

if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools.These may be signs of a serious condition. See your doctor. with other acid reducers

Warnings

Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers Do not use if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools.These may be signs of a serious condition. See your doctor. with other acid reducers Ask a doctor before use if you have had heartburn over 3 months. This may be a sign of a more serious condition. …

Pregnancy & breastfeeding

If pregnant or breast-feeding, ask a health professional before use.

General information only, not dosing advice. Always follow the leaflet in your pack and your doctor or pharmacist.

Check your pack of Zilatec 150 Tablets

Add the expiry date on your pack for a full Trust Score.

3 free checks left today Official sources: NAFDAC Green Book & recalls · WHO · U.S. FDA · NLM RxNorm

About Zilatec 150 Tablets

What is in Zilatec 150 Tablets?

Zilatec 150 Tablets contains Ranitidine (Ranitidine Hydrochloride) (150 mg), as tablet, according to its NAFDAC registration record.

Is Zilatec 150 Tablets registered with NAFDAC?

Yes. Zilatec 150 Tablets is listed on the NAFDAC register under registration number A4-1681, and its registration is active as of 28 October 2026.

Has Zilatec 150 Tablets been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Zilatec 150 Tablets in our automatically synced alert list.

How can I check that my pack of Zilatec 150 Tablets is genuine?

Run a free authenticity scan with the NAFDAC number A4-1681, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

What is Zilatec 150 Tablets used for?

(s) relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages (Summarised from the official U.S. FDA label for ranitidine (ranitidine hydrochloride). Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Zilatec 150 Tablets? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.